SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Monday, February 23, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international pa.

SAN RAMON, Calif.--(BUSINESS WIRE)--Five9, Inc. (Nasdaq: FIVN), provider of the Intelligent CX Platform, today provided details for its fourth quarter and fiscal year 2025 financial results conference call on Thursday, February 19, 2026, at 4:30 p.m. Eastern Time. Participants may register for the webinar at 4:30 p.m. Eastern Time on February 19, 2026, by clicking here. A replay will be available shortly after the conclusion of the live event. Both the live webcast and replay will be available.

CAMPBELL, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, February 12, 2026.

BOSTON, Feb. 02, 2026 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited automotive shopping site in the U.S.1, announced it will issue a press release reporting financial results for the quarter and fiscal year ended December 31, 2025, after the close of the market on February 19, 2026.

SAN CARLOS, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today the closing of its previously announced underwritten public offering of 12,650,000 shares of common stock at a public offering price of $50.00 per share.

Fourth Quarter 2025 Net Income of $169.3 million or $0.75 per Diluted Share Fourth Quarter 2025 Adjusted Net Operating Income (Non-GAAP) of $168.4 million or $0.75 per Diluted Share Full Year 2025 Net Income of $738.3 million or $3.14 per Diluted Share Full Year 2025 Adjusted Net Operating Income (Non-GAAP) of $738.4 million or $3.14 per Diluted Share MILWAUKEE, Feb. 2, 2026 /PRNewswire/ -- MGIC Investment Corporation (NYSE: MTG) today reported operating and financial results for the fourth quarter of 2025. Tim Mattke, CEO of MTG and Mortgage Guaranty Insurance Corporation ("MGIC") said, "We closed 2025 on a strong note, …

CAMBRIDGE, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted two newly-hired employees options to purchase an aggregate of 132,675 shares of Akebia's common stock on January 30, 2026.

INDIANAPOLIS, Feb. 2, 2026 /PRNewswire/ -- Simon ®, a real estate investment trust engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations, today reported results for the quarter and twelve months ended December 31, 2025. "I am very pleased with our fourth-quarter results, which caps another impressive year of performance for our Company," said David Simon, Chairman, Chief Executive Officer and President.

DENVER, Feb. 2, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2025. "Our strong platform delivered once again in 2025, providing high quality, innovative care to our patients and achieving the financial targets we set out at the beginning of the year despite a challenging environment," said Javier Rodriguez, CEO of DaVita.

FOSTER CITY, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that it has granted as of February 1, 2026 equity inducement awards to two new employees under the terms of the 2022 Employment Inducement Award Plan, as amended.

LA JOLLA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that on January 30, 2026, the Compensation Committee of Equillium's Board of Directors granted inducement awards consisting of nonstatutory stock options to purchase an aggregate of 59,750 shares of common stock to two new employees under Equillium's 2024 Inducement Plan.

NEW YORK--(BUSINESS WIRE)--Optimum Communications (NYSE: OPTU) will host a conference call on Thursday, February 12, 2026, at 8:30 a.m. ET to discuss financial and operating results for the fourth quarter and full year ended December 31, 2025. The conference call will be led by Dennis Mathew, Chairman and CEO, and Marc Sirota, CFO. Presentation materials, including Optimum's earnings release, earnings results presentation and trended schedule, will be available at 7:00 a.m. ET, prior to the con.

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2025 fourth quarter earnings release on February 12, 2026, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 fourth quarter results will be held on Friday, February 13 at 11:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference.

Acquisitions add 1.5 GW of load capacity, expanding energy-advantaged portfolio with on-site power generation TeraWulf's platform more than doubles to 2.8 GW across five sites, supporting 250 – 500 MW of targeted new contracted capacity annually EASTON, Md., Feb. 02, 2026 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated digital infrastructure, today announced the expansion of its digital and power infrastructure portfolio through the acquisition of two strategically located brownfield infrastructure sites in Hawesville, Kentucky and Charles County, Maryland.

ENGLEWOOD CLIFFS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (Nasdaq: ATLN), a global provider of staffing and workforce solutions, today announced the appointment of Kevin J.

NEEDHAM, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that on January 31, 2026, the Compensation Committee of Candel's Board of Directors (the Board) granted to one new employee, stock options to purchase an aggregate of 6,600 shares of the Company's common stock, with a per share exercise price of $5.84.

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company was informed by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) of a negative trend vote on its Marketing Authorization Application (MAA) for trofinetide for the treatment of Rett syndrome, following its recent CHMP oral explanation. Subject to the outcome of the CHMP vote in February, Acadia intends to request a re-examination of the opinion b.

MILPITAS, Calif.--(BUSINESS WIRE)--SolarEdge Technologies, Inc. (NASDAQ: SEDG), a global leader in smart energy technology, will report financial results for the fourth quarter and the full year ended December 31, 2025 before market open on Wednesday, February 18, 2026. Management will host a conference call at 8:00 A.M. ET on Wednesday, February 18, 2026, to discuss these results. The call will be available, live, to interested parties by dialing: United States/Canada Toll Free: +1 800-343.

TSXV: ITR; NYSE American: ITRG VANCOUVER, BC , Feb. 2, 2026 /PRNewswire/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is pleased to announce that, further to its news release dated December 17, 2025, it has filed a Feasibility Study Technical Report for its wholly-owned DeLamar Gold and Silver Heap Leach Project ("DeLamar" or the "Project"), comprised of the DeLamar and Florida Mountain deposits, located in southwestern Idaho. The technical report was prepared in accordance with National Instrument 43-101 - Standards for Disclosure for Mineral Projects with Forte Dynamics, Inc. as the lead author and …

TEMPLE, Ga.--(BUSINESS WIRE)--Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”), a leading provider of building product solutions and cutting-edge access control technologies for the self-storage and other commercial and industrial sectors, today announced a repricing of its first lien term loan. The repricing, which was privately placed with institutional lenders in the syndicated loan market, reduces the applicable interest rate on the $551 million first lien term loan by.